HEADER IMMUNE SYSTEM/PEPTIDE 10-NOV-10 2XXM TITLE CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN IN TITLE 2 COMPLEX WITH A CAMELID VHH AND THE CAI PEPTIDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAPSID PROTEIN P24; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 278-352; COMPND 5 SYNONYM: HIV-1 CAPSID PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMELID VHH 9; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: INHIBITOR OF CAPSID ASSEMBLY; COMPND 13 CHAIN: T; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 12721; SOURCE 5 STRAIN: NL4-3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODONPLUS-RIL; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11C; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: VICUGNA PACOS; SOURCE 12 ORGANISM_COMMON: ALPACA; SOURCE 13 ORGANISM_TAXID: 30538; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 20 ORGANISM_TAXID: 32630 KEYWDS IMMUNE SYSTEM-PEPTIDE COMPLEX, CAPSID INHIBITOR, PROTEIN BINDING, KEYWDS 2 PROTEIN INTERFACE, VIRUS ASSEMBLY EXPDTA X-RAY DIFFRACTION AUTHOR S.IGONET,M.C.VANEY,V.BARTONOVA,J.HELMA,U.ROTHBAUER,H.LEONHARDT, AUTHOR 2 E.STURA,H.-G.KRAUSSLICH,F.A.REY REVDAT 2 14-AUG-19 2XXM 1 AUTHOR JRNL REVDAT 1 12-OCT-11 2XXM 0 JRNL AUTH S.IGONET,M.C.VANEY,V.BARTONOVA,J.HELMA,U.ROTHBAUER, JRNL AUTH 2 H.LEONHARDT,E.STURA,H.-G.KRAUSSLICH,F.A.REY JRNL TITL TARGETING HIV-1 VIRION FORMATION WITH NANOBODIES JRNL TITL 2 -IMPLICATIONS FOR THE DESIGN OF ASSEMBLY INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 22242 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1145 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.73 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.52 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2336 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2244 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2217 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2115 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.09 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 119 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1496 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.96 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.24930 REMARK 3 B22 (A**2) : -0.51780 REMARK 3 B33 (A**2) : 0.76700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.193 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.116 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.105 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.106 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.100 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1546 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2087 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 540 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 42 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 224 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1546 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 201 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1951 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.88 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.33 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.80 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XXM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1290046197. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 5 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : DYNAMICALLY BENDABLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22400 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2XV6 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG4000, 200MM AMMONIUM ACETATE, REMARK 280 100MM SODIUM ACETATE PH 4.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 66.86000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.75500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 66.86000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 19.75500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2009 LIES ON A SPECIAL POSITION. REMARK 375 HOH B2057 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 219 REMARK 465 GLY A 220 REMARK 465 MET B -1 REMARK 465 ALA B 0 REMARK 465 GLN B 1 REMARK 465 VAL B 2 REMARK 465 GLN B 3 REMARK 465 HIS B 114 REMARK 465 HIS B 115 REMARK 465 HIS B 116 REMARK 465 HIS B 117 REMARK 465 HIS B 118 REMARK 465 HIS B 119 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1114 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1115 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT T 1012 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A8O RELATED DB: PDB REMARK 900 HIV CAPSID C-TERMINAL DOMAIN REMARK 900 RELATED ID: 2ITG RELATED DB: PDB REMARK 900 CATALYTIC DOMAIN OF HIV-1 INTEGRASE: ORDERED ACTIVE SITE IN THE REMARK 900 F185H CONSTRUCT REMARK 900 RELATED ID: 2H3Z RELATED DB: PDB REMARK 900 STRUCTURE OF THE HIV-1 MATRIX PROTEIN BOUND TO DI- C4- REMARK 900 PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE REMARK 900 RELATED ID: 2H3Q RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HIV-1 MYRMA BOUND TO DI-C4- REMARK 900 PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE REMARK 900 RELATED ID: 1HIW RELATED DB: PDB REMARK 900 TRIMERIC HIV-1 MATRIX PROTEIN REMARK 900 RELATED ID: 1WKN RELATED DB: PDB REMARK 900 A PLAUSIBLE MODEL OF FULL-LENGTH INTEGRASEDNA COMPLEX REMARK 900 RELATED ID: 9HVP RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH A-74704 REMARK 900 RELATED ID: 1QS4 RELATED DB: PDB REMARK 900 CORE DOMAIN OF HIV-1 INTEGRASE COMLEXED WITH MG++ AND 1-(5- REMARK 900 CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H- TETRAZOL-5-YL)-PROPENONE REMARK 900 RELATED ID: 1BL3 RELATED DB: PDB REMARK 900 CATALYTIC DOMAIN OF HIV-1 INTEGRASE REMARK 900 RELATED ID: 2H3I RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HIV-1 MYRISTOYLATED MATRIX PROTEIN REMARK 900 RELATED ID: 1A43 RELATED DB: PDB REMARK 900 STRUCTURE OF THE HIV-1 CAPSID PROTEIN DIMERIZATION DOMAINAT 2.6A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1BIZ RELATED DB: PDB REMARK 900 HIV-1 INTEGRASE CORE DOMAIN REMARK 900 RELATED ID: 1WJB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 REMARK 900 INTEGRASE (D FORM), NMR, 40 STRUCTURES REMARK 900 RELATED ID: 1K6Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A TWO-DOMAIN FRAGMENT OF HIV- 1INTEGRASE REMARK 900 RELATED ID: 1GWP RELATED DB: PDB REMARK 900 STRUCTURE OF THE N-TERMINAL DOMAIN OF THE MATURE HIV -1 CAPSID REMARK 900 PROTEIN REMARK 900 RELATED ID: 2H3V RELATED DB: PDB REMARK 900 STRUCTURE OF THE HIV-1 MATRIX PROTEIN BOUND TO DI- C8- REMARK 900 PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE REMARK 900 RELATED ID: 1B9F RELATED DB: PDB REMARK 900 MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH REMARK 900 CATALYTIC ACTIVITY REMARK 900 RELATED ID: 2H3F RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HIV-1 MA PROTEIN REMARK 900 RELATED ID: 4PHV RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) PROTEASE COMPLEX WITH N, REMARK 900 N-BIS(2(R)-HYDROXY-1(S)-INDANYL)- 2,6-(R,R)- DIPHENYLMETHYL-4- REMARK 900 HYDROXY-1,7- HEPTANDIAMIDE REMARK 900 RELATED ID: 1B92 RELATED DB: PDB REMARK 900 MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH REMARK 900 CATALYTIC ACTIVITY REMARK 900 RELATED ID: 1BAJ RELATED DB: PDB REMARK 900 HIV-1 CAPSID PROTEIN C-TERMINAL FRAGMENT PLUS GAG P2 DOMAIN REMARK 900 RELATED ID: 1BHL RELATED DB: PDB REMARK 900 CACODYLATED CATALYTIC DOMAIN OF HIV-1 INTEGRASE REMARK 900 RELATED ID: 2B4J RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE RECOGNITION BETWEEN HIV- 1INTEGRASE AND REMARK 900 LEDGF/P75 REMARK 900 RELATED ID: 1UPH RELATED DB: PDB REMARK 900 HIV-1 MYRISTOYLATED MATRIX REMARK 900 RELATED ID: 1BIS RELATED DB: PDB REMARK 900 HIV-1 INTEGRASE CORE DOMAIN REMARK 900 RELATED ID: 1M9D RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN REMARK 900 (1-146) O-TYPE CHIMERA COMPLEX. REMARK 900 RELATED ID: 1AFV RELATED DB: PDB REMARK 900 HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3 REMARK 900 RELATED ID: 5HVP RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH ACETYL-PEPSTATIN (NY5 STRAIN) REMARK 900 RELATED ID: 1B9D RELATED DB: PDB REMARK 900 MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH REMARK 900 CATALYTIC ACTIVITY REMARK 900 RELATED ID: 2HMX RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATRIX PROTEIN 2HMX 3 REMARK 900 RELATED ID: 2X2D RELATED DB: PDB REMARK 900 ACETYL-CYPA:HIV-1 N-TERM CAPSID DOMAIN COMPLEX REMARK 900 RELATED ID: 1AUM RELATED DB: PDB REMARK 900 HIV CAPSID C-TERMINAL DOMAIN (CAC146) REMARK 900 RELATED ID: 1AK4 RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A BOUND TO THE AMINO-TERMINAL DOMAIN OF HIV-1 REMARK 900 CAPSID REMARK 900 RELATED ID: 1BIU RELATED DB: PDB REMARK 900 HIV-1 INTEGRASE CORE DOMAIN COMPLEXED WITH MG++ REMARK 900 RELATED ID: 1BI4 RELATED DB: PDB REMARK 900 CATALYTIC DOMAIN OF HIV-1 INTEGRASE REMARK 900 RELATED ID: 1WJD RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 REMARK 900 INTEGRASE (E FORM), NMR, 38 STRUCTURES REMARK 900 RELATED ID: 2HVP RELATED DB: PDB REMARK 900 HIV-1 PROTEASE REMARK 900 RELATED ID: 1ITG RELATED DB: PDB REMARK 900 HIV-1 INTEGRASE (CATALYTIC DOMAIN COMPRISING RESIDUES 50 - 212) REMARK 900 MUTANT WITH GLY-SER-HIS APPENDED TO THE N- TERMINUS AND PHE 185 REMARK 900 REPLACED BY LYS (INS(47-49), F185K) REMARK 900 RELATED ID: 2XT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C- TERMINAL DOMAIN REMARK 900 (146-231) IN COMPLEX WITH A CAMELID VHH. REMARK 900 RELATED ID: 2XXC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A CAMELID VHH RAISED AGAINST THE HIV-1 CAPSID REMARK 900 PROTEIN C-TERMINAL DOMAIN. REMARK 900 RELATED ID: 2XV6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C- TERMINAL DOMAIN REMARK 900 (146-220) IN COMPLEX WITH A CAMELID VHH. DBREF 2XXM A 146 220 UNP P12497 POL_HV1N5 278 352 DBREF 2XXM B -1 119 PDB 2XXM 2XXM -1 119 DBREF 2XXM T 1 11 PDB 2XXM 2XXM 1 11 SEQRES 1 A 75 SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY PRO LYS SEQRES 2 A 75 GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR LYS THR SEQRES 3 A 75 LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS ASN TRP SEQRES 4 A 75 MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN PRO ASP SEQRES 5 A 75 CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY ALA THR SEQRES 6 A 75 LEU GLU GLU MET MET THR ALA CYS GLN GLY SEQRES 1 B 121 MET ALA GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU SEQRES 2 B 121 VAL GLN ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SEQRES 3 B 121 SER GLY SER PHE PHE MET SER ASN VAL MET ALA TRP TYR SEQRES 4 B 121 ARG GLN ALA PRO GLY LYS ALA ARG GLU LEU ILE ALA ALA SEQRES 5 B 121 ILE ARG GLY GLY ASP MET SER THR VAL TYR ASP ASP SER SEQRES 6 B 121 VAL LYS GLY ARG PHE THR ILE THR ARG ASP ASP ASP LYS SEQRES 7 B 121 ASN ILE LEU TYR LEU GLN MET ASN ASP LEU LYS PRO GLU SEQRES 8 B 121 ASP THR ALA MET TYR TYR CYS LYS ALA SER GLY SER SER SEQRES 9 B 121 TRP GLY GLN GLY THR GLN VAL THR VAL SER SER HIS HIS SEQRES 10 B 121 HIS HIS HIS HIS SEQRES 1 T 11 ILE THR PHE GLU ASP LEU LEU ASP TYR TYR GLY HET ACT B1114 4 HET ACT B1115 4 HET ACT T1012 4 HETNAM ACT ACETATE ION FORMUL 4 ACT 3(C2 H3 O2 1-) FORMUL 7 HOH *180(H2 O) HELIX 1 1 SER A 149 ILE A 153 5 5 HELIX 2 2 PRO A 160 GLU A 175 1 16 HELIX 3 3 SER A 178 LEU A 190 1 13 HELIX 4 4 ASN A 195 LEU A 205 1 11 HELIX 5 5 THR A 210 THR A 216 1 7 HELIX 6 6 SER B 27 SER B 31 5 5 HELIX 7 7 ASP B 61 LYS B 64 5 4 HELIX 8 8 LYS B 83 THR B 87 5 5 HELIX 9 9 THR T 2 GLY T 11 1 10 SHEET 1 BA 4 VAL B 5 SER B 7 0 SHEET 2 BA 4 LEU B 18 ALA B 23 -1 O SER B 21 N SER B 7 SHEET 3 BA 4 ILE B 77 MET B 82 -1 O LEU B 78 N CYS B 22 SHEET 4 BA 4 PHE B 67 ASP B 72 -1 O THR B 68 N GLN B 81 SHEET 1 BB 6 GLY B 10 GLN B 13 0 SHEET 2 BB 6 THR B 107 SER B 112 1 O GLN B 108 N GLY B 10 SHEET 3 BB 6 ALA B 88 ALA B 94 -1 O ALA B 88 N VAL B 109 SHEET 4 BB 6 VAL B 33 GLN B 39 -1 O ALA B 35 N LYS B 93 SHEET 5 BB 6 GLU B 46 ARG B 52 -1 O GLU B 46 N ARG B 38 SHEET 6 BB 6 THR B 57 TYR B 59 -1 O VAL B 58 N ALA B 50 SSBOND 1 CYS B 22 CYS B 92 1555 1555 2.04 CISPEP 1 SER A 146 PRO A 147 0 -1.13 SITE 1 AC1 5 ASP B 74 HOH B2087 GLU T 4 LEU T 7 SITE 2 AC1 5 ASP T 8 SITE 1 AC2 3 GLU A 187 ARG B 52 GLN B 108 SITE 1 AC3 5 GLY A 208 HOH A2069 GLY B 42 LYS B 43 SITE 2 AC3 5 ASP T 5 CRYST1 133.720 39.510 35.210 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007478 0.000000 0.000000 0.00000 SCALE2 0.000000 0.025310 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028401 0.00000 MASTER 364 0 3 9 10 0 5 6 0 0 0 17 END